Kurz A - Search Results

1

Reduction of regional cerebral blood flow and cognitive impairment in patients with Alzheimer's disease: evaluation of an observer-independent analytic approach.

Hirsch C, Bartenstein P, Minoshima S, Mösch D, Willoch F, Buch K, Schad D, Schwaiger M, Kurz A. Hirsch C, et al. Among authors: kurz a. Dement Geriatr Cogn Disord. 1997 Mar-Apr;8(2):98-104. doi: 10.1159/000106613. Dement Geriatr Cogn Disord. 1997. PMID: 9065322

2

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A. Drzezga A, et al. Among authors: kurz a. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. doi: 10.1007/s00259-003-1194-1. Epub 2003 May 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 12764551 Clinical Trial.

3

Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT.

Bartenstein P, Minoshima S, Hirsch C, Buch K, Willoch F, Mösch D, Schad D, Schwaiger M, Kurz A. Bartenstein P, et al. Among authors: kurz a. J Nucl Med. 1997 Jul;38(7):1095-101. J Nucl Med. 1997. PMID: 9225797 Free article.

4

Impaired cross-modal inhibition in Alzheimer disease.

Drzezga A, Grimmer T, Peller M, Wermke M, Siebner H, Rauschecker JP, Schwaiger M, Kurz A. Drzezga A, et al. Among authors: kurz a. PLoS Med. 2005 Oct;2(10):e288. doi: 10.1371/journal.pmed.0020288. Epub 2005 Sep 20. PLoS Med. 2005. PMID: 16159306 Free PMC article.

5

Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.

Drzezga A, Grimmer T, Riemenschneider M, Lautenschlager N, Siebner H, Alexopoulus P, Minoshima S, Schwaiger M, Kurz A. Drzezga A, et al. Among authors: kurz a. J Nucl Med. 2005 Oct;46(10):1625-32. J Nucl Med. 2005. PMID: 16204712 Free article. Clinical Trial.

6

Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease.

Kurz A, Riemenschneider M, Buch K, Willoch F, Bartenstein P, Müller U, Guder W. Kurz A, et al. Alzheimer Dis Assoc Disord. 1998 Dec;12(4):372-7. doi: 10.1097/00002093-199812000-00020. Alzheimer Dis Assoc Disord. 1998. PMID: 9876968

7

Cerebral glucose metabolism in patients with AD and different APOE genotypes.

Drzezga A, Riemenschneider M, Strassner B, Grimmer T, Peller M, Knoll A, Wagenpfeil S, Minoshima S, Schwaiger M, Kurz A. Drzezga A, et al. Among authors: kurz a. Neurology. 2005 Jan 11;64(1):102-7. doi: 10.1212/01.WNL.0000148478.39691.D3. Neurology. 2005. PMID: 15642911

8

The Alzheimer variant of lewy body disease: a pathologically confirmed case-control study.

Perneczky R, Mösch D, Neumann M, Kretzschmar H, Müller U, Busch R, Förstl H, Kurz A. Perneczky R, et al. Among authors: kurz a. Dement Geriatr Cogn Disord. 2005;20(2-3):89-94. doi: 10.1159/000086472. Epub 2005 Jun 23. Dement Geriatr Cogn Disord. 2005. PMID: 15976504 Free article.

9

Longitudinal changes of cerebral glucose metabolism in semantic dementia.

Diehl-Schmid J, Grimmer T, Drzezga A, Bornschein S, Perneczky R, Forstl H, Schwaiger M, Kurz A. Diehl-Schmid J, et al. Among authors: kurz a. Dement Geriatr Cogn Disord. 2006;22(4):346-51. doi: 10.1159/000095624. Epub 2006 Sep 4. Dement Geriatr Cogn Disord. 2006. PMID: 16954690

10

Cerebrospinal protein tau is elevated in early Alzheimer's disease.

Riemenschneider M, Buch K, Schmolke M, Kurz A, Guder WG. Riemenschneider M, et al. Among authors: kurz a. Neurosci Lett. 1996 Jul 19;212(3):209-11. doi: 10.1016/0304-3940(96)12810-x. Neurosci Lett. 1996. PMID: 8843109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

854 results

Search Page

Filters